secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0001104659-24-083959
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.08, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell Therapeutics sets 2024 annual meeting for Sep 16, 2024
----------------------------------------------------------------------

- Annual meeting to be held virtually on Sep 16, 2024 at 10:00 a.m. Eastern time.
- Record date for voting is August 12, 2024.
- Stockholder proposals for proxy inclusion due by August 12, 2024.
- Director nominations under universal proxy rules due by August 9, 2024.
- Meeting more than 30 days later than 2023 meeting; new deadlines supersede prior ones.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924083959/0001104659-24-083959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924083959/tm2420468d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-083959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer